Months after the U.S. FDA approved a device with the potential to close the source of many atrial fibrillation-related strokes, hospitals, cardiologists and patients find themselves in a holding pattern increasingly common for newly emerging therapies: They are waiting for the CMS to issue a national coverage determination for LAA occlusion.
Prompt response to cardiac arrest is critical; seconds lost reduce the chances for patient recovery. While other rescue procedures like CPR do help and buy rescuers time, when a shock is needed, it’s imperative for the equipment to work well and, in some cases, provide rescuers with feedback.
Patient safety is a major concern for every health professional. However, for cardiologists, the interaction of certain drugs and heart conditions make vigilance against contraindications and complications an added battle. EMRs can help, but only if they work reliably and clinicians observe alerts.
In the U.S., the state of blood pressure monitoring is changing. Recommendations published in February by the U.S. Preventive Services Task Force suggest the use of 24-hour ambulatory, home or automated blood pressure monitoring instead of conventional office measurements for the diagnosis of hypertension.